Parmantier & Cie. GmbH

BRIEF

published on 02/25/2025 at 11:01, 1 year 8 months ago

INDUS Holding AG: Strong Prospects Affirmed by Parmantier & Cie.

Acquisitions Share Buyback Investment Strategy INDUS Holding AG Financial Growth
PRESS RELEASE

published on 02/25/2025 at 10:56, 1 year 8 months ago

PARMANTIER&CIE.: INDUS Holding AG Continues Growth Path – Buy Recommendation Confirmed
PARMANTIER&CIE. reaffirms buy recommendation for INDUS Holding AG, citing strong financial figures, acquisitions, and share buyback program. Detailed growth strategy outlook to be presented on March 24 & 25, 2025

Growth Strategy Acquisitions Financial Figures INDUS Holding AG PARMANTIER&CIE.
BRIEF

published on 02/10/2025 at 11:22, 1 year 8 months ago

PARMANTIER & CIE. Updates on CLINUVEL Pharmaceuticals Strategy

Market Expansion Corporate Strategy SCENESSE® CLINUVEL Pharmaceuticals PhotoCosmetics Line
PRESS RELEASE

published on 02/10/2025 at 11:17, 1 year 8 months ago

PARMANTIER & CIE. Provides an Update on CLINUVEL Pharmaceuticals
CLINUVEL Pharmaceuticals Ltd. adjusts corporate strategy for targeted expansion & development processes, focusing on key projects & introducing 'PhotoCosmetics' product line

Corporate Strategy CLINUVEL Pharmaceuticals Ltd. Targeted Expansion Development Processes PhotoCosmetics
BRIEF

published on 11/18/2024 at 15:05, 1 year 11 months ago

PARMANTIER & CIE. Updates Coverage on INDUS Holding AG

Share Buyback Economic Environment SMEs Sustainable Investments INDUS Holding AG
PRESS RELEASE

published on 11/18/2024 at 15:00, 1 year 11 months ago

PARMANTIER & CIE. Continues Comprehensive Coverage of INDUS Holding AG
Parmantier & Cie. updates coverage on INDUS Holding AG, highlighting positive operational developments amidst economic challenges. INDUS implements share buyback programs for sustained growth

Operational Developments INDUS Holding AG Economic Challenges PARMANTIER & CIE. Share Buyback Programs
BRIEF

published on 10/02/2024 at 11:32, 2 years 1 month ago

PARMANTIER & CIE. Initiates Coverage on Lodgyslife AG

Corporate Finance Acquisition Strategy DACH Region PARMANTIER & CIE. Lodgyslife AG Bloomberg/parmantiercie; Short Code: {DS FMG <GO>} Www.parmantiercie.com/research Www.lodgyslife.com
PRESS RELEASE

published on 10/02/2024 at 11:27, 2 years 1 month ago

PARMANTIER & CIE. initiates coverage on lodgyslife AG
PARMANTIER & CIE. initiates coverage of lodgyslife AG in the DACH region, consolidating campsites. Focus on sensitive acquisition process to address sellers' needs

DACH Region PARMANTIER & CIE. Lodgyslife AG Consolidation Strategy Sensitive Acquisition
BRIEF

published on 09/09/2024 at 15:15, 2 years 1 month ago

PARMANTIER & CIE. Initiates Coverage of CLINUVEL Pharmaceuticals Ltd.

Pharmaceuticals Coverage CLINUVEL Melanocortin SCENESSE
PRESS RELEASE

published on 09/09/2024 at 15:10, 2 years 1 month ago

PARMANTIER & CIE. is starting coverage of CLINUVEL Pharmaceuticals Ltd.
PARMANTIER & CIE. initiates coverage of CLINUVEL Pharmaceuticals Ltd., a leader in melanocortin-based therapies for skin disorders and cancer prevention. Includes SCENESSE® for rare disease EPP and nutraceuticals division for skin health improvement

PARMANTIER & CIE. CLINUVEL Pharmaceuticals Ltd. Melanocortin-based Therapies SCENESSE® Nutraceuticals Division

Published on 11/06/2026 at 22:15, 5 hours 50 minutes ago

Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 15 hours 5 minutes ago

Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 15 hours 35 minutes ago

Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 15 hours 35 minutes ago

Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 10:00, 18 hours 5 minutes ago

Mongolia Tax Audit

View all ACCESSWIRE

Published on 11/06/2026 at 20:15, 7 hours 50 minutes ago

African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 19:15, 8 hours 50 minutes ago

EQS-Adhoc: ABO Energy GmbH & Co. KGaA suspends the interest payment on the bond 2024/2029 due on 8 November 2026.
Published on 11/06/2026 at 19:00, 9 hours 5 minutes ago

Finexity AG: FINEXITY issues 2026/2030 bond with a minimum of 7.00% p.a. – either conventionally in a securities account or as a crypto security in a wallet
Published on 11/06/2026 at 18:32, 9 hours 33 minutes ago

EQS-Adhoc: Finexity AG: FINEXITY issues 2026/2030 bond
Published on 11/06/2026 at 18:00, 10 hours 5 minutes ago

ARVERNE GROUP: Number shares and voting rights

View all EQS

Published on 11/06/2026 at 18:00, 10 hours 5 minutes ago

ICADE - PR - S&P credit rating
Published on 11/06/2026 at 18:00, 10 hours 5 minutes ago

DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 11/06/2026 at 17:54, 10 hours 10 minutes ago

Disclosure of Share Capital and Voting Rights as of October 31, 2026
Published on 11/06/2026 at 17:35, 10 hours 30 minutes ago

Disclosure of the number of shares and the total number of voting rights as of October 31, 2026
Published on 11/06/2026 at 11:05, 17 hours ago

voting rights

View all LES ECHOS COMFI WIRE

News